Event

9

June 2021

Healthcare Outlook 2021

7:45am-2:00pm | EST - Virtual Venue,

This marquee summit will feature industry executives, policy makers and key government officials in conversation to provide an in-depth look at the healthcare landscape in Canada and its links to economy recovery and future growth, innovation and national wellbeing.

The event will consist of 4 in-depth conversations, a fireside chat with Minister Hajdu, and networking opportunities.
Visit the event schedule for a full breakdown: https://bit.ly/3b8Sb6o

Early Bird Ticket Price, effective until May 28
Individual Ticket: $25 + HST

Ticket price, after May 28:
Individual Ticket: $49 + HST

Important:
-A unique link will be sent to each individual attendee 2 days prior to the event date. You will be required to enter the email address you registered with to enter the digital event.
-If you have any questions, please contact julia@economicclub.ca

* The views expressed on the Economic Club platform are not that of the Economic Club or its affiliates but of the speakers alone and the organizations they represent. *

Healthcare Outlook 2021

Alex Boyd

Reporter
Toronto Star

Alex Boyd

Alex Boyd is a national reporter for the Toronto Star who is writing a lot about COVID vaccines these days. She’s also a co-recipient of the R. James Travers Foreign Corresponding Fellowship for 2021 and working on a project about inequalities in the global vaccine roll out.

Dr. Alan Bernstein

President & CEO
CIFAR

Dr. Alan Bernstein

Alan has been President & CEO of CIFAR since 2012, responsible for developing and leading the institute’s overall strategic direction. He is one of Canada’s leading scientists and was an early champion of women in science and young scientists.

After receiving his PhD from the University of Toronto and following postdoctoral work at the Imperial Cancer Research Fund in London, Dr. Bernstein joined the Ontario Cancer Institute. In 1985, he joined the Samuel Lunenfeld Research Institute, was named its Associate Director in 1988 and served as Director of Research from 1994 to 2000. In 2000, he was asked to become the founding President of the Canadian Institutes of Health Research (CIHR), Canada’s federal agency for the support of health research. In that capacity, he led the transformation of health research in Canada. In 2010, Bernstein became Executive Director of the Global HIV Vaccine Enterprise in New York, an international alliance of researchers and funders charged with accelerating the search for an HIV vaccine.

Author of over 225 scientific publications, Alan made landmark contributions to the study of stem cells, blood cell formation (hematopoiesis), and cancer. He chairs or is a member of advisory and review boards in Canada, the U.S., U.K., Italy, and Australia. He serves as co-chair of the Scientific Advisory Committee for Stand Up 2 Cancer Canada, is a member of the Sabin-Aspen Vaccine Science and Policy Group, and the Scientific Advisory Committee of the Bill and Melinda Gates Foundation. In May 2020 he was appointed to Canada’s COVID-19 Vaccine Task Force and in February 2021, he was appointed Chair of the Variants of Concern, Scientific Advisory Council.

Alan’s contributions to science and science policy have been recognized with numerous awards and honorary degrees, including Officer of the Order of Canada, the Order of Ontario, the McLaughlin Medal from the Royal Society of Canada, the Award of Excellence from the Genetics Society of Canada, the Gairdner Foundation Wightman Award, induction into the Canadian Medical Hall of Fame, and the 2017 Henry Friesen International Prize in Health Research.

Dr. Ali A. Houshmand

President
Rowan University

Dr. Ali A. Houshmand

Dr. Ali A. Houshmand became Rowan University’s seventh president in 2012 after serving for approximately six years as provost/senior vice president, CEO and interim president. Inaugurated Sept. 20, 2013, Houshmand is a dynamic leader whose personal connection with students, employees, alumni, government leaders, the business community and the public has become a hallmark of his presidency. A lifelong believer in the power of education, Houshmand holds master’s and doctoral degrees in industrial and operations engineering. His entrepreneurial approach to growing the University has focused on four goals: increasing access, improving quality, ensuring affordability and promoting economic development. His success is evident. Under Houshmand, Rowan has evolved from a well-regarded state school to a rising Carnegie-classified national research university with two medical schools. For the second year, Rowan has been named the fourth fastest-growing research university among public doctoral institutions. Rowan offers bachelor’s through doctoral programs to nearly 20,000 students through its campuses in Glassboro, Camden, Stratford, and online.

Dr. Geneviève Moineau

President and CEO
Association of Faculties of Medicine of Canada (AFMC)

Dr. Geneviève Moineau

Geneviève Moineau, MD, FRCPC, is President and CEO of the Association of Faculties of Medicine of Canada (AFMC).

Dr. Moineau received her MD at the University of Ottawa and completed her Pediatric Residency at the University of Toronto’s Hospital for Sick Children. She is Professor in the Department of Paediatrics and Emergency Medicine at the University of Ottawa and practices Pediatric Emergency Medicine at the Children’s Hospital of Eastern Ontario.

At the University of Ottawa, Dr Moineau served as Associate Dean, Undergraduate Medical Education, where she led the faculty through a complete curriculum renewal and an outstanding MD program accreditation result. She was named Honorary Class President by the graduating class on seven occasions, has a Faculty of Medicine Leadership Award established in her name, is the recipient of the Faculty of Medicine 2010 Award of Distinction and in 2019, she received the Alumni Exceptional Leadership Award.

Dr. Moineau joined the AFMC in 2011, when she took the position of VP Education and Secretary to CACMS and CACME. Since 2013 as President and CEO, she has led the development of a memorandum of understanding with the Association of American Medical Colleges (AAMC), the American Medical Association, and the Canadian Medical Association on the Canadianization of medical school accreditation. She has also negotiated a collaboration agreement with the Conférence Internationale des Doyens et des Facultés de Médecine d’Expression Française (CIDMEF).

Dr. Moineau has been instrumental in AFMC’s success in advocacy for physician resource planning to meet Canada’s future needs for physician supply. In addition, she is highly sought internationally as an expert on accreditation in medical education. She is an avid promoter for social accountability of faculties of medicine in Canada and abroad.

Dr. Joy Johnson

President and Vice-Chancellor
Simon Fraser University

Dr. Joy Johnson

Joy Johnson is president and vice-chancellor of Simon Fraser University, and professor in its Faculty of Health Sciences.

As president, Joy is committed to enhancing student learning experiences, working towards Indigenous reconciliation, and advancing equity, diversity and inclusion across the university.

Prior to her appointment as president, Joy served as SFU’s vice-president, research and international from 2014 to 2020 where she oversaw the evolution of cutting-edge research, innovation, and international engagement across eight faculties. Under her leadership, SFU’s research income grew from $103 million in 2014 to $161 million in 2020 – the fastest growth of any Canadian university. Other major accomplishments include the launch of a groundbreaking big data initiative, hosting one of Canada’s largest supercomputers and establishing a university-wide innovation strategy.

Prior to SFU, Joy had a distinguished career in academics and research. She completed her PhD in nursing at the University of Alberta, and joined the University of British Columbia as a professor in the School of Nursing. Her commitment to research led her to the role of scientific director with the Canadian Institutes of Health Research Institute of Gender and Health, where she is credited for shaping the Canadian research landscape to ensure gender is considered in health research.

Joy is an elected Fellow of the Canadian Academy of Health Sciences, a Fellow of the Royal Society of Canada, and has co-authored more than 180 peer-reviewed articles.

Dr. Mohamed Lachemi

President and Vice-Chancellor
Ryerson University

Dr. Mohamed Lachemi

Dr. Mohamed Lachemi is president and vice-chancellor of Ryerson University, first appointed in 2016 and reappointed to a second term concluding in 2026. An internationally recognized researcher and accomplished academic administrator, he has been a key contributor to the growth and development of Ryerson over a transformational time in the university’s history. A Ryerson professor of civil engineering since 1998, he has served in progressively senior roles, including dean of the faculty of engineering and architectural science, and provost and vice-president academic. As president he has promoted the establishment of Ryerson as a global university, overseen the development of Rogers Cybersecure Catalyst – a national centre for cybersecurity, and navigated approvals for a new and innovative law school.

A graduate of l'Université des Sciences et de la Technologie d'Oran in Algeria and L'Université de Sherbrooke (MASc and PhD), Dr. Lachemi is a member of the National Research Council of Canada, Fellow of the Canadian Society for Civil Engineering, Fellow of the Canadian Academy of Engineering, Board member of Trillium Health Partners and Chair of the Education Section of the Campaign Cabinet, United Way of Greater Toronto.

Dr. Scott A. Halperin

Professor of Pediatrics and Microbiology and Immunology
Dalhousie University

Dr. Scott A. Halperin

Dr. Scott Halperin is a Professor of Pediatrics and Microbiology and Immunology at Dalhousie University in Halifax, Nova Scotia. He is a practising pediatric infectious disease specialist with an active research program that focuses on the diagnosis, treatment, and prevention of pertussis and other vaccine-preventable diseases. As the Director of the Canadian Center for Vaccinology and Nominated Principal Investigator of the Canadian Immunization Research Network (CIRN), he has played a foundational role in the establishment of these and other Canadian collaborative research networks undertaking evaluative vaccine research that informs public health policy and practice. Dr. Halperin’s contributions to combatting COVID-19 include serving on the Nova Scotia Vaccine Expert Panel and the national COVID-19 Immunity Task Force Leadership Group and as Co-Chair of the Vaccine Surveillance Reference Group.

Hon. Patty Hajdu

Minister of Health
Government of Canada

Hon. Patty Hajdu

The Honourable Patty Hajdu was first elected as the Member of Parliament for Thunder Bay—Superior North in 2015.

Minister Hajdu is a strong advocate for women’s rights, youth employment, and affordable housing.

Before entering politics, Minister Hajdu was the Executive Director of Shelter House Thunder Bay and a co-author of the Thunder Bay Drug Strategy. She also previously worked in public health and focused on drug policy, youth development, and homelessness.

She is a compassionate advocate for Thunder Bay—Superior North and all of Canada, believing that a more inclusive country benefits everyone. As Member of Parliament, she remains firmly focused on ensuring every Canadian has a fair shot at success.

Minister Hajdu is a graduate of Lakehead University and earned a Master’s degree in Public Administration from the University of Victoria.

Juggy Sihota

Vice-President
Consumer Health, TELUS

Juggy Sihota

A telecom executive with more than 25 years of leadership experience, Juggy has enjoyed a fulfilling and rewarding career with TELUS leading many emerging technology businesses and operations. She has a well-established reputation for building and leading high performing teams with some of the highest engagement scores and engagement transformations across the company. Juggy is known for her unrelenting focus on quality and efficiency combined with a genuine concern and commitment for all who work with her. Juggy has led ground-breaking service development initiatives and diverse portfolios, and gained invaluable experience in strategy, marketing and operations management at TELUS overseeing many different portfolios throughout her tenure.

Currently, as the Vice President of Consumer Health, Juggy is responsible for the national strategy, execution and operation of the Consumer Health business unit for TELUS Health. Juggy believes in empowering Canadians with the right tools, information and support so they can live happier and healthier lives. She is revolutionising access to healthcare in Canada with important products she has launched such as Canada’s fastest growing and highest customer rated virtual care service Babylon by TELUS Health, curated health content in the TELUS Healthy Living Network, personal emergency response systems for vulnerable seniors (largest Canadian-owned provider in Canada), personal health records and more. She was also the executive producer for the critical documentary “PainKiller” on the opioid crisis
ravaging our country with the intent to build awareness and to end the stigma around addiction.

TELUS Health transforms information into better health outcomes by ensuring valuable medical information is in the right hands at the right time. TELUS Health is also the largest healthcare IT company in Canada. TELUS is the leading provider of virtual care, electronic medical records, pharmacy management software, remote patient monitoring and health benefits claims management in Canada.

Community leadership is a critical component of Juggy’s leadership story. Juggy is the Vice Chair for the VGH & UBC Hospital Foundation Board, she is a Director for the Vancouver International Airport Authority (YVR), the Canadian Chamber of Commerce, the Greater Vancouver Board of Trade and the Canadian Men’s Health Foundation. Juggy also currently serves as an advisor to the City of Vancouver on racial and social justice issues. She previously served as a director on the Justice Institute of British Columbia, the Vancouver Community Board, and the Vancouver Board of
Trade’s Women’s Leadership Council.

Juggy is the recipient of the Diversity Champion Award at TELUS. This award recognises leaders who are champions of all diversity and celebrates those who leverage diversity of thought to help advance business strategy. Juggy received the
Leadership Excellence Trailblazer Award by Canadian Women in Communications and Technology (WCT) as well as the Forty Under 40 award in BC by Business in Vancouver for her business achievements, inspirational leadership and community contributions. In 2019, Vancouver Magazine recognized her as one of the most powerful 50 people in BC. In 2021 she also received the Influential Women in Business Award by BIV and the WeQual Business Transformation Leadership Award for the Americas.

Juggy holds an MBA from Queen’s University in Kingston, Ontario. She has also completed Executive Development programs at Harvard and INSEAD.

Karimah Es Sabar

CEO & Partner
Quark Venture LP

Karimah Es Sabar

Karimah Es Sabar is a highly-recognized Canadian life sciences leader with global experience and a successful career spanning multi-national pharmaceutical/biotechnology companies, startups, not-for-profit organizations and venture investment firms. She has provided leadership in marketing, business development, strategic and global alliances, public private partnerships, translation strategies and execution, innovation ecosystems, entrepreneurship in startups, and in bioscience investments.

Ms. Es Sabar is the founding CEO & Partner at Quark Venture LP, a global venture capital firm, and Director of the Global Health Sciences [GHS] Fund focused on bioscience investment in therapeutics, vaccines, medical devices, digital health, AI and convergent disruptive technology companies.

Prior to joining Quark Venture, Ms. Es Sabar was CEO & President of the Centre for Drug Research and Development (CDRD]; CEO & President of LifeSciences BC; and she has held several senior management positions in the biopharmaceutical industry, most notably at Sanofi Pasteur. She also co-founded and enabled several startup companies.

Ms. Es Sabar has received multiple awards and recognitions for her leadership and pioneering work, including Canada’s Most Powerful Women: Top 100 Award. She holds an Executive Certificate in Management and Leadership from the MIT Sloan School of Management; a MSc degree in Neurochemistry from the Institute of Psychiatry, University of London, England; and a BSc Joint Honours degree in Biochemistry/Chemistry from the University of Salford in Manchester, England.

Ms. Es Sabar has served on numerous boards, currently she is Board Chair of TRIUMF Innovations and Glyconet, and serves on boards of V Wave, PHEMI, ARTMS, Canary Medical and Sitka. Since 2017 she is Chair of the Health/Biosciences Economic Strategy Table (Government of Canada) and Member of the Industry Strategy Council (Government of Canada)

Mark Sakamoto

Media Personality & EVP
Think Research

Mark Sakamoto

Mark is the Executive Vice President for Think. A lawyer by training, Mark has enjoyed a rich and varied career, having worked at a national law firm and served as a senior political advisor to a national party leader. Prior to joining our Executive Team, Mark worked as an Executive Manager for the Canadian Broadcast Corporation where he led negotiations for hundreds of content deals. He is an entrepreneur and investor in digital health and digital media and has been instrumental in driving the growth of Think Research. In 2014, he authored his first book, Forgiveness: A Gift from My Grandparents, which went on to be a #1 national best seller.

Michael Green

President and CEO
Canada Health Infoway

Michael Green

Michael Green is a strong leader and a creative, strategic thinker who has an international reputation and a proven track record of transforming health care through the use of digital health. He has leveraged international research and innovation to advance the digital health agenda, create jobs and stimulate economic growth in Canada. Michael has been President and CEO of Canada Health Infoway since August 2014.

Michael envisions a future where all Canadians can access their health information and interact with their providers from the device of their choice. As President and CEO of Canada Health Infoway, he is leading a national strategy called Driving Access to Care to realize this vision.

Nathalie Landry

Executive Vice President, Scientific and Medical Affairs
Medicago

Nathalie Landry

Nathalie Landry is a dynamic biotech leader with more than 25 years of experience leading teams and programs to successful milestones. At Medicago, she oversees a multidisciplinary team in charge of R&D, preclinical and clinical development, clinical immunology, as well as scientific and medical affairs. Nathalie represents Medicago at numerous international conferences and meetings and is the co-author of several scientific publications and patents. She joined Medicago in 2000 as Director of Strategic Development and later became Senior Director of Product Development. In 2007, she was named Vice President.

Prior to joining Medicago she worked for a start-up biotech company developing and producing anticancer compounds, where she held various positions. Nathalie earned a Master's degree in microbiology-immunology in 1989 and an MBA in 1997, both from Laval University.

Pamela Fralick

President
Innovative Medicines Canada

Pamela Fralick

Driven by a life-long commitment to improving Canadians’ health and well-being, Pamela works with the country’s research-based pharmaceutical companies to ensure that all Canadians have access to the medicines they need, when they need them, and that Canada remains an attractive place to invest in the life sciences. Her unique perspective on the policy issues of the day is informed by her decades of working closely with patients and researchers to find solutions to some of our most pressing healthcare challenges.
Prior to IMC, Pamela was President and CEO of the Canadian Cancer Society, where she led the transformation of the organization’s operational and governance structures, helping to strengthen its position as the country’s leading cancer-fighting charity.
Her patient-centric perspective is also shaped by past leadership roles at the Canadian Healthcare Association (now HealthCareCAN), the Canadian Physiotherapy Association, the Health Action Lobby (HEAL), the Health Charities Coalition of Canada (HCCC), CAMH (Centre for Addiction and Mental Health) and the Canadian Centre on Substance Abuse.

Our Sponsors

Telus Interac Green Shield Canada